MORTON GROVE PHARMACEUTICALS I has a total of 12 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, environmental technology and machines are LDS TECHNOLOGIES INC, MEDPROJECT PHARMA ENTW UND VERTRIEBSGESELLSCHAFT MBH and L T T KENKYUSHO KK.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Canada | 1 | |
#5 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Delmarre David | 5 |
#2 | Gao Danchen | 5 |
#3 | Groves Michael J | 4 |
#4 | Centeno Carlos-Julian Sison | 4 |
#5 | Egbaria Kamel F | 4 |
#6 | Gudi Sivaramaprasad | 3 |
#7 | Weldele Meagan Erica | 3 |
#8 | Dagar Aparna | 3 |
#9 | Opawale Foyeke | 3 |
#10 | Surapaneni Naga Mallika | 3 |
Publication | Filing date | Title |
---|---|---|
WO2008144355A2 | Stable, self-microemulsifying fenofibrate compositions | |
EP2051696A2 | Stable liquid levetiracetam compositions and methods | |
WO2007143382A2 | Oral liquid loratadine formulations and methods | |
WO2007016352A2 | Oral liquid losartan compositions | |
US2006293382A1 | Stable warfarin sodium liquid formulation and method of making same | |
US6960563B2 | Spontaneous emulsions containing cyclosporine |